Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.97 |
| ▸ | MAPT | P10636 | 8/20 | 0.97 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.97 |
| ▸ | RECQL | P46063 | 7/20 | 0.97 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.97 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.97 |
| ▸ | XDH | P47989 | 7/20 | 0.97 |
| ▸ | FTO | Q9C0B1 | 7/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.97 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.97 |
| ▸ | APP | P05067 | 6/20 | 0.97 |
| ▸ | POLH | Q9Y253 | 6/20 | 0.97 |
| ▸ | POLB | P06746 | 5/20 | 0.97 |
| ▸ | TP53 | P04637 | 5/20 | 0.97 |
| ▸ | IPMK | Q8NFU5 | 5/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetin SCHEMBL31152043 | 1.00 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL31152042 | 1.00 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29353785 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL118425 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29351036 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29723041 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL31507620 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL19723 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL17629824 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP3A4KDM4E | |
| Quercetin SCHEMBL29683606 | 0.97 | MEN1 (0.92) | MEN1KMT2ACYP1A2CYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111053780-A | Oxcetitinib pharmaceutical composition and application thereof | 正大天晴药业集团股份有限公司 | 2020-04-24 | — | — | CN | claimed |
| CN-111053776-A | Afatinib pharmaceutical composition and application thereof | 正大天晴药业集团股份有限公司 | 2020-04-24 | — | — | CN | claimed |
| CN-107821794-A | A kind of feed addictive for preventing animal diarrhea | 广州骊加生物科技有限公司 | 2018-03-23 | — | — | CN | claimed |
| CN-107668327-A | A kind of application of Quercetin metallo-chelate in animal feed additive | 广州微特加生物工程有限公司 | 2018-02-09 | — | — | CN | claimed |
| WO-2012122295-A2 | TREATMENT FOR PANCREATIC ADENOCARCINOMA AND OTHER CANCERS OF EPITHELIAL ORIGIN | NED BIOSYSTEMS, INC. (US) | 2012-09-13 | — | — | WO | claimed |
| EP-0570475-A1 | PHARMACEUTICAL PREPARATION FOR THE THERAPY OF TUMORS, PARTICULARLY OVARIAN AND HAEMOPOIETIC SYSTEM TUMORS, CONTAINING QUERCETIN COMPOUNDS AS ACTIVE SUBSTANCES | ROMEO, Francesco (IT) | 1993-11-24 | — | — | EP | claimed |
| WO-1992013851-A1 | PHARMACEUTICAL PRODUCT FOR THE THERAPY OF TUMORS, PARTICULARLY OVARIAN AND HAEMOPOIETIC SYSTEM TUMORS, CONTAINING QUERCETIN COMPOUNDS AS ACTIVE SUBSTANCES | ROMEO, FRANCESCO (IT) | 1992-08-20 | — | — | WO | claimed |
| CN-119320373-A | Quercetin and marigold complex as well as preparation method and application thereof | 广州立达尔生物科技股份有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-111053780-A | Oxcetitinib pharmaceutical composition and application thereof | 正大天晴药业集团股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| CN-111053776-A | Afatinib pharmaceutical composition and application thereof | 正大天晴药业集团股份有限公司 | 2020-04-24 | — | — | CN | disclosed |
| CN-109847062-A | A kind of Quercetin metal nano drug and its preparation method and application | 中山大学 | 2019-06-07 | — | — | CN | disclosed |
| CN-107821794-A | A kind of feed addictive for preventing animal diarrhea | 广州骊加生物科技有限公司 | 2018-03-23 | — | — | CN | disclosed |
| CN-107668327-A | A kind of application of Quercetin metallo-chelate in animal feed additive | 广州微特加生物工程有限公司 | 2018-02-09 | — | — | CN | disclosed |
| US-20100323984-A1 | COSMETIC ORAL AND/OR PARENTERAL USE OF GLUCOSAMINE OPTIONALLY IN COMBINATION WITH AT LEAST ONE POLYPHENOL COMPOUND, AND CORRESPONDING COMPOSITION | LABORATOIRES INNEOV (FR) | 2010-12-23 | — | — | US | disclosed |
| CN-100441590-C | Compounds like quercetol and metal complex of their glycosides and uses | UNIV ZHONGSHAN (CN) | 2008-12-10 | — | — | CN | disclosed |
| CN-101220014-A | Meletin with cell apoptosis inductive effect and metallic complex of glycoside compounds thereof | UNIV CHONGQING (CN) | 2008-07-16 | — | — | CN | disclosed |
| CN-1817896-A | Compounds like quercetol and metal complex of their glycosides and uses | UNIV ZHONGSHAN (CN) | 2006-08-16 | — | — | CN | disclosed |
| EP-0570475-A1 | PHARMACEUTICAL PREPARATION FOR THE THERAPY OF TUMORS, PARTICULARLY OVARIAN AND HAEMOPOIETIC SYSTEM TUMORS, CONTAINING QUERCETIN COMPOUNDS AS ACTIVE SUBSTANCES | ROMEO, Francesco (IT) | 1993-11-24 | — | — | EP | disclosed |
| WO-1992013851-A1 | PHARMACEUTICAL PRODUCT FOR THE THERAPY OF TUMORS, PARTICULARLY OVARIAN AND HAEMOPOIETIC SYSTEM TUMORS, CONTAINING QUERCETIN COMPOUNDS AS ACTIVE SUBSTANCES | ROMEO, FRANCESCO (IT) | 1992-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100323984-A1 | COSMETIC ORAL AND/OR PARENTERAL USE OF GLUCOSAMINE OPTIONALLY IN COMBINATION WITH AT LEAST ONE POLYPHENOL COMPOUND, AND CORRESPONDING COMPOSITION | GLA, PNN, OGT | MEN1 2781/4885KMT2A 4082/4885CYP1A2 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.